Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alexander Bodkin

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The American Journal of Psychiatry|November 2, 2002
Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatientsJ Alexander Bodkin, Jay D Amsterdam
Journal of Clinical Psychopharmacology|November 18, 2006
Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trialJay D Amsterdam, J Alexander Bodkin
The Journal of Nervous and Mental Disease|July 1, 2020
A Survey of American Psychiatrists Concerning Medication Prior Authorization RequirementsBrian S Barnett, J Alexander Bodkin
CNS Drugs|November 16, 2018
Opioidergic Agents as Antidepressants: Rationale and PromiseParnika P Saxena, J Alexander Bodkin
International Journal of Psychiatry in Medicine|September 25, 2004
Hypochondriacal concerns in panic disorder and major depressive disorder: a comparisonRussell Noyes, Catherine L Woodman, J Alexander Bodkin, et al.
Journal of Anxiety Disorders|October 24, 2006
Is PTSD caused by traumatic stress?J Alexander Bodkin, Harrison G Pope, Michael J Detke, et al.
The American Journal of Psychiatry|January 29, 2005
Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophreniaJ Alexander Bodkin, Samuel G Siris, Paul C Bermanzohn, et al.
The Journal of Clinical Psychiatry|June 16, 2012
Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposuresChi-Un Pae, J Alexander Bodkin, Kimberly Blanchard Portland, et al.
Journal of Psychoactive Drugs|June 21, 2024
Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and TranylcypromineBrian S Barnett, Curtis J Koons, Vincent Van den Eynde, et al.
Harvard Review of Psychiatry|April 25, 2007
The price of a gift: an approach to receiving gifts from patients in psychiatric practiceDavid H Brendel, James Chu, Jennifer Radden, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The American Journal of Psychiatry|November 2, 2002
Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatientsJ Alexander Bodkin, Jay D Amsterdam
Journal of Clinical Psychopharmacology|November 18, 2006
Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trialJay D Amsterdam, J Alexander Bodkin
The Journal of Nervous and Mental Disease|July 1, 2020
A Survey of American Psychiatrists Concerning Medication Prior Authorization RequirementsBrian S Barnett, J Alexander Bodkin
CNS Drugs|November 16, 2018
Opioidergic Agents as Antidepressants: Rationale and PromiseParnika P Saxena, J Alexander Bodkin
International Journal of Psychiatry in Medicine|September 25, 2004
Hypochondriacal concerns in panic disorder and major depressive disorder: a comparisonRussell Noyes, Catherine L Woodman, J Alexander Bodkin, et al.
Journal of Anxiety Disorders|October 24, 2006
Is PTSD caused by traumatic stress?J Alexander Bodkin, Harrison G Pope, Michael J Detke, et al.
The American Journal of Psychiatry|January 29, 2005
Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophreniaJ Alexander Bodkin, Samuel G Siris, Paul C Bermanzohn, et al.
The Journal of Clinical Psychiatry|June 16, 2012
Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposuresChi-Un Pae, J Alexander Bodkin, Kimberly Blanchard Portland, et al.
Journal of Psychoactive Drugs|June 21, 2024
Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and TranylcypromineBrian S Barnett, Curtis J Koons, Vincent Van den Eynde, et al.
Harvard Review of Psychiatry|April 25, 2007
The price of a gift: an approach to receiving gifts from patients in psychiatric practiceDavid H Brendel, James Chu, Jennifer Radden, et al.
Pageof 2